Results 31 to 40 of about 61,637 (50)

A retrospective case-control study:modified trocar peritoneal dialysis catheter implantation and open peritoneal dialysis catheter implantation

open access: yesLinchuang shenzangbing zazhi, 2021
Objective To explore the clinical efficacy of modified Trocar peritoneal dialytic catheter implantation versus open peritoneal dialytic catheter implantation.Methods For this single-center retrospective study,a total of 125 patients were reviewed between
Gao Fang, Wang Shao-qing, Mao Nan
doaj  

Applications of rituximab in the treatment of renal diseases

open access: yesLinchuang shenzangbing zazhi, 2021
As a monoclonal antibody targeting CD20 on the surface of B lymphocytes,rituximab causes the dissolution of B cells through immune action.Plasma cells lack CD20 antigen.Rituximab is both effective and safe for lupus nephritis,ANCA-associated vasculitis ...
Liu Zi, Hu Zhi-juan
doaj  

Research advances of single-cell RNA sequencing in kidney

open access: yesLinchuang shenzangbing zazhi, 2021
Composed of multiple cell types,kidney is an organ with highly complex structures and functions.Thus it is quite important to clarify the gene transcription map and changes of various types and subtypes of cells under physiological and pathological ...
Wang Xin-yao, Deng Zhen-ling, Wang Yue
doaj  

Research adavances of podocyte damage mechanism and traditional Chinese medicine intervention in diabetic kidney disease

open access: yesLinchuang shenzangbing zazhi, 2021
Diabetic kidney disease(DKD)is the primary cause of chronic kidney disease and end-stage renal disease and the pathogenesis has remained elusive.Podocyte injury plays a key role in the occurrence and development of DKD.This review summarized the ...
Wen Xiao-chen   +2 more
doaj  

Treatment of anemia of chronic kidney disease caused by ANCA associated vasculitis with roxadustat:one case report with a literature review

open access: yesLinchuang shenzangbing zazhi, 2021
罗沙司他作为一种里程碑式的新药用于治疗慢性肾脏病(chronic kidney disease,CKD)贫血,临床试验已证实其疗效及安全性,目前临床上已逐渐开始使用。本文报告1例罗沙司他治疗抗中性粒细胞胞质抗体(antineutrophil cytoplasmic antibody,ANCA)相关性血管炎所致CKD贫血患者,该患者在罗沙司他用药前后均使用促红细胞生成素治疗CKD贫血,
Xiao Xiang   +5 more
doaj  

Mitochondrial disease with renal damage:one case report

open access: yesLinchuang shenzangbing zazhi, 2021
线粒体病是由于线粒体结构和功能异常导致的一组疾病,临床表现多样,缺乏特异性,可累及全身多个系统,本文旨在报道1例线粒体病合并肾损伤、糖尿病的病例,以期为临床实践提供参考。病例资料患者,男,41岁,于2018年6月11日以"发现血糖高10年,纳差、乏力3个月"为主诉入院,10年来不规律服用降糖药物和胰岛素,未控制饮食,糖化血红蛋白波动于10%~13%;1年前始出现血肌酐逐渐升高(2017年4月30日血肌酐72.9μmol/L)。2018年7月10日因上腹闷痛就诊我院,
Deng Jin-xiu   +5 more
doaj  

One case of cholesterol crystal embolism nephropathy

open access: yesLinchuang shenzangbing zazhi, 2020
胆固醇结晶栓塞(cholesterol crystal embolism,CCE)是一种累及多系统的疾病,其形成主要由于胆固醇结晶脱落阻塞肢端、肾、肠系膜、皮肤等器官的微动脉,引起相应的临床表现,又因肾脏血供丰富,且邻近腹主动脉,而成为最常受累的器官[1]。目前随着人口老龄化,动脉粥样硬化的发病率增高及介入治疗的普及应用,使得CCE的发病率也日益增多。由于该病确诊多需要活检证实,未经活检证实或症状不典型者常不能得到正确的诊断治疗,因此其发病率经常被低估,也容易造成临床漏诊 ...
ZHANG De-yu   +5 more
doaj  

《临床肾脏病杂志》稿约

open access: yesLinchuang shenzangbing zazhi, 2021
《临床肾脏病杂志》是由湖北省科学技术协会主管,中华医学会武汉分会、湖北省微循环学会主办,国内外公开发行的肾脏病专业性学术刊物。本刊为中国科技论文统计源期刊(中国科技核心期刊),自2004年起,收录入国家科技部中国科技论文与引文数据库(CSTPC)。2008年起变更为月刊。
doaj  

A case of acute renal failure caused by overdose of benzbromarone

open access: yesLinchuang shenzangbing zazhi, 2020
苯溴马隆是促进尿酸排泄的药物,常规剂量发生不良反应较少且轻微,主要有肝损伤的风险[1-2],但肾功能损害的临床报道较少[3-4],我科 2019年 6月 26 日收治超量服苯溴马隆9片(50 mg/片)致急性肾衰竭1例,报道如下。病例资料患者,男,29岁,既往体健,每年体检肾功能、尿常规均未见异常。此次主因"右足部肿痛4 d,血肌酐升高伴尿量减少3 d"于2019年6月26日14时55分入院。患者于4 ...
ZHAO Chun-yan, GUO Yan-cong
doaj  

Efficacy of tacrolimus or cyclophosphamide combined with glucocorticoids in the treatment of idiopathic membranous nephropathy

open access: yesLinchuang shenzangbing zazhi, 2018
Objective To observe the clinical efficacy and safety of tacrolimus(TAC)or cyclophosphamide(CTX)combined with glucocorticoids in treatment of idiopathic membranous nephropathy.Methods A retrospective study was conducted on46 patients who had been ...
MAO Wen-li   +4 more
doaj  

Home - About - Disclaimer - Privacy